Prospective comparison of transient elastography, MRI and serum scores for grading steatosis and detecting non-alcoholic steatohepatitis in bariatric surgery candidates - ScienceDirect
IJMS | Free Full-Text | Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD
Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
Frontiers | Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
Discrepancies between Nonalcoholic and Metabolic-associated Fatty Liver Disease by Multiple Steatosis Assessment
Nonalcoholic Fatty Liver Disease in Lean/Nonobese and Obese Individuals: A Comprehensive Review on Prevalence, Pathogenesis, Clinical Outcomes, and Treatment
Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination | Scientific Reports
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
Cureus | Estimation of Liver Fat by FibroScan in Patients With Nonalcoholic Fatty Liver Disease | Article
Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies - The Lancet Diabetes & Endocrinology
Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of liver steatosis using the Controlled Attenuation Parameter (CAP) as the reference method. | Semantic Scholar
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD | Nature Reviews Gastroenterology & Hepatology
Cureus | Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease
Screening for non‐alcoholic fatty liver disease in community setting: A cohort study using controlled attenuation parameter‐transient elastography - Teeratorn - 2020 - JGH Open - Wiley Online Library
Frontiers | Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Nutrients | Free Full-Text | Overview of Non-Alcoholic Fatty Liver Disease ( NAFLD) and the Role of Sugary Food Consumption and Other Dietary Components in Its Development
The Specialists
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
IJMS | Free Full-Text | Advances in the Diagnosis and Treatment of Non-Alcoholic Fatty Liver Disease
Incidence and disease severity of non-alcoholic fatty liver disease among people living with HIV in Thailand
Biomedicines | Free Full-Text | Nonalcoholic Fatty Liver Disease (NAFLD): Pathogenesis and Noninvasive Diagnosis
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
Comparison of controlled attenuation parameter (CAP) values in patients... | Download Scientific Diagram
